1
/
of
1
ELK Biotechnology
SKU:ELK9646
General F-E3(Free Estriol) ELISA Kit
General F-E3(Free Estriol) ELISA Kit
Regular price
$376.00 USD
Regular price
Sale price
$376.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
General F-E3(Free Estriol) ELISA Kit
Overview
| Product name: | F-E3(Free Estriol) ELISA Kit |
| Reactivity: | General |
| Alternative Names: | F-E3; Free Estriol |
| Assay Type: | Competitive Inhibition |
| Sensitivity: | 0.218 ng/mL |
| Standard: | 40 ng/mL |
| Detection Range: | 0.63-40 ng/mL |
| Sample Type: | Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids |
| Assay Length: | 2h |
| Research Area: | Endocrinology;Reproductive science;Hormone metabolism; |
| Test principle: | This assay employs the competitive inhibition enzyme immunoassay technique. The microtiter plate provided in this kit has been pre-coated with F-E3 protein. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to F-E3. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of F-E3 in the samples is then determined by comparing the OD of the samples to the standard curve. |
Standard curve
| Concentration (ng/mL) | OD | Corrected OD |
|---|---|---|
| 40.00 | 0.215 | — |
| 20.00 | 0.310 | — |
| 10.00 | 0.596 | — |
| 5.00 | 0.895 | — |
| 2.50 | 1.169 | — |
| 1.25 | 1.585 | — |
| 0.63 | 1.869 | — |
| 0.00 | 2.157 | — |

Precision
Intra-assay Precision (Precision within an assay):CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-assay Precision (Precision between assays):CV%<10%
Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.
Recovery
Matrices listed below were spiked with certain level of recombinant F-E3 and the recovery rates were calculated by comparing the measured value to the expected amount of F-E3 in samples.
| Matrix | Recovery range | Average |
|---|---|---|
| serum(n=5) | 83-95% | 89% |
| EDTA plasma(n=5) | 79-93% | 86% |
| Heparin plasma(n=5) | 92-105% | 98% |
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of F-E3 and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Matrix | 1:2 | 1:4 | 1:8 | 1:16 |
|---|---|---|---|---|
| serum(n=5) | 86-93% | 91-103% | 87-98% | 92-99% |
| EDTA plasma(n=5) | 89-99% | 83-96% | 98-104% | 88-101% |
| Heparin plasma(n=5) | 87-96% | 92-105% | 89-102% | 92-101% |
Share
